Literature DB >> 8299688

A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules.

A C Olsen1, L O Pedersen, A S Hansen, M H Nissen, M Olsen, P R Hansen, A Holm, S Buus.   

Abstract

A direct and sensitive biochemical assay to measure the interaction in solution between peptides and affinity-purified major histocompatibility complex (MHC) class I molecules has been generated. Specific binding reflecting the known class I restriction of cytotoxic T cell responses was obtained. Adding an excess of beta 2-microglobulin (beta 2m) significantly increased the rate of peptide association, but it did not affect the rate of dissociation. Binding was complicated by a rapid and apparently irreversible loss of functional MHC class I at 37 degrees C which might limit the life span of empty MHC class I thereby preventing the inadvertent exchange of peptides at the target cell surface. All class I molecules tested bound peptides of the canonical octa- to nona-meric length. However, one class I molecule, Kk, also bound peptides, which were much longer suggesting that the preference of class I molecules for short epitopes is not absolute and may be caused by factors other than the peptide-MHC class I binding event itself.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8299688     DOI: 10.1002/eji.1830240218

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

Review 1.  Major histocompatibility complex class I binding predictions as a tool in epitope discovery.

Authors:  Claus Lundegaard; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunology       Date:  2010-05-26       Impact factor: 7.397

2.  Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides.

Authors:  Daniel Gebreselassie; Hans Spiegel; Stanislav Vukmanovic
Journal:  Hum Immunol       Date:  2006-09-20       Impact factor: 2.850

3.  Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay.

Authors:  Mikkel Harndahl; Michael Rasmussen; Gustav Roder; Søren Buus
Journal:  J Immunol Methods       Date:  2010-10-31       Impact factor: 2.303

4.  Shared fine specificity between T-cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex.

Authors:  A Stryhn; P S Andersen; L O Pedersen; A Svejgaard; A Holm; C J Thorpe; L Fugger; S Buus; J Engberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

5.  A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.

Authors:  P S Andersen; A Stryhn; B E Hansen; L Fugger; J Engberg; S Buus
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

6.  Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

Authors:  John Sidney; Scott Southwood; Carrie Moore; Carla Oseroff; Clemencia Pinilla; Howard M Grey; Alessandro Sette
Journal:  Curr Protoc Immunol       Date:  2013-02

7.  MHC-I peptide binding activity assessed by exchange after cleavage of peptide covalently linked to β2-microglobulin.

Authors:  Mollie M Jurewicz; Richard A Willis; Vasanthi Ramachandiran; John D Altman; Lawrence J Stern
Journal:  Anal Biochem       Date:  2019-06-13       Impact factor: 3.365

Review 8.  Peptide binding to MHC class I molecules: implications for antigenic peptide prediction.

Authors:  K C Parker; M Shields; M DiBrino; A Brooks; J E Coligan
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

9.  The three-dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chain.

Authors:  E J Collins; D N Garboczi; M N Karpusas; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

10.  T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides.

Authors:  S L Larsen; L O Pedersen; S Buus; A Stryhn
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.